Table 3.
All participants* |
Standard treatment group only | Intensive treatment group only | |||
---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | HR (95% CI) | P value for interaction effect by treatment group | |
Cardiovascular event | 1.9 (1.06, 3.52) | 0.032 | 2.50 (1.0, 6.1) | 1.7 (0.75, 3.83) | >0.2 |
Cardiovascular mortality | 3.7 (1.3, 10.4) | 0.012 | 8.6 (1.9, 37.7) | 2.1 (0.51, 8.9) | 0.184 |
All-cause mortality | 2.4 (1.1, 5.1) | 0.024 | 6.7 (2.7, 16.6) | 0.92 (0.23, 3.8) | 0.019 |
*Adjusted for treatment group, cardiovascular risk (as estimated by UKPDS score), history of cardiovascular event, insulin at baseline, and eGFR.